Navigation Links
SIRO Clinpharm Announces a Fabulous Date With the Dueling Pianos
Date:5/31/2012

EWING, New Jersey, May 31, 2012 /PRNewswire/ --

The Dueling Pianos will perform live at the Courtyard Marriott, Philadelphia, on June 25th. The event is slated 6.30 pm onwards and promises a great musical evening to its audience.

The Dueling Pianos, based out of the Philly area since March of 1990, have been performing at nightclubs, colleges, parties and corporate events throughout the east coast, from Boston to North Carolina, out to Anaheim, CA and also down to Biloxi, MS.  

This event is being organized by SIRO Clinpharm, a global clinical research organization, recently awarded with the Life Science Leader CRO Leadership award for capabilities in regulatory, productivity, reliability and accessibility.

Gopakumar Menon, CEO, SIRO Clinpharm, expressed his pleasure on receiving an award that represents the voice of the industry. "The award in the regulatory, productivity, reliability and accessibility aspects underscores what we at SIRO have always believed in - invest in quality people for quality delivery. This is an affirmation from our clients on our commitment to delivery."

Bruce Hardy, Senior Vice President, Global Business Development said, "SIRO has established strategic partnerships with top 20 biopharma and medical devices clients, bringing together significant experience in clinical data management, medical writing and biostatistics and statistical programming. We have rolled out clinical monitoring in North America and my team and I look forward to personally welcome clients through this event."        

The show is an invitation only event. Invitations can be requested for on http://www.siroclinpharm.com/events/index.html or you may write to bd@siroclinpharm.com

About SIRO Clinpharm

SIRO Clinpharm, winner of the Frost & Sullivan Indian Clinical Research Organization of the year 2011 award is a drug development solutions provider to the global healthcare industry. Our subject expertise gives us an edge in data management, medical writing, biostatistics & clinical trial management. Having a successful track record of 16 years, SIRO works with most top global biopharma & medical device companies. Our therapeutic experience includes but is not limited to oncology, diabetes, cardiology, infectious diseases & respiratory system. We offer flexible business models across service verticals based on client needs.

The company has offices in India, Malaysia, USA, and Israel and in Europe at Germany, Romania, Estonia, Greece, Czech Republic and Spain.

Ruchi Sanganeria
Executive - Corporate Marketing
SIRO Clinpharm
T: +91-22-2584-8000
E: ruchi.sanganeria@siroclinpharm.com



'/>"/>
SOURCE SIRO Clinpharm
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
2. SIRO Clinpharm and CambReg Ltd Strategic Alliance to Offer Regulatory Services in Europe
3. DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm
4. SIRO Clinpharm Collaborates with Mediscis, Broadens Early Phase Drug Development Expertise
5. SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS
6. SIRO Clinpharms Nimita Limaye Elected as Chairperson of Society for Clinical Data Management (SCDM)
7. SIRO Clinpharm Expands Presence in Asia
8. SIRO Clinpharm Announces Appointment of Gopakumar Menon as Chief Executive Officer to Lead the Global Clinical Research Organization
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/8/2017)... 8, 2017  Less than a month ago, amateur ... 200,000 companies, including hospital networks, in over 150 countries. ... of the largest online extortion attempts ever recorded. With ... it is imperative that providers understand where the risks ... this — and many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus ... from 9 am to 3 pm to present to graduate students exciting new and ... an original curriculum project led by The Health Improvement Service of the Western Health ...
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, ... families and business owners in North Central West Virginia, is embarking on a ... differently abled residents in the region. , The Stepping Stones organization offers a ...
(Date:6/22/2017)... Indianapolis, IN (PRWEB) , ... June 22, 2017 ... ... employee benefits advisory organization, is pleased to welcome Whipple & Company as its ... on the clear purpose of balancing their clients’ risk while tailoring optimized benefit ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... awards for environmental excellence. Maryland Recycling Network has awarded the Baltimore VA Medical ... Outstanding Small Government Program Award for its efforts to promote waste reduction and ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... that Claritas Capital, a Nashville-based private equity firm, has invested $3.35 million in ... for some time, and Claritas Capital offers the smart money, speed to market ...
Breaking Medicine News(10 mins):